Bisphosphonates increase risk of atypical femur fracture, study finds

Study data published Tuesday in JAMA suggest that women who take bisphosphonates for several years have an increased risk of atypical femur fracture. However, the researchers note that the risk of such fractures are rare and are outweighed by the benefits of the drugs for most patients.

**Published in "First Word"